Enterprise Value Evaluation Of Medical Devices Based On Modified EVA Model

The challenges of COVID-19,the enhancement of health awareness of Chinese residents and the continuous improvement of the national medical insurance system have enabled the rapid development of the medical industry,and the medical device enterprises,as one of the three sub-tracks of the medical industry,are also thriving.In China,the number of medical device enterprises is large,and investors face large risks when investing,so the demand for reasonable value evaluation of medical equipment enterprises is also high.Reasonable evaluation of medical equipment enterprises can help investors to make reasonable investment and trading.Therefore,it is particularly important how to choose the appropriate evaluation method and scientifically evaluate the value of medical device companies.This paper finds that due to the particularity of the medical device industry and its ability to grow sustainably,the traditional valuation method is not applicable in some aspects.Therefore,the market method is proposed to obtain a valuation more in line with the actual situation.Medical equipment industry in recent years in the outbreak and policy of the external environment rapid development,EVA valuation calculation is the excess return of the enterprise,is the company’s future value appreciation and value-added ability of sustainability,reflects the intrinsic value of the company,can reflect the enterprise competitiveness,so EVA value evaluation method is suitable for the current rapid development of medical equipment enterprise value assessment,can enrich the enterprise valuation system,for contemporary diversified enterprise type enterprise value evaluation.As the leader in the medical device industry,Mindray Medical is in line with the characteristics of high investment and high return and strong innovation in the medical device industry.In addition,when calculating the EVA value with Mindray Medical Co.,Ltd.as the case object,it does not simply predict the future operating revenue based on the overall operating revenue and growth rate,but combines the characteristics of Mindray Medical’s rich business portfolio.Mindray medical focus on life information and support,medical imaging,in vitro diagnosis of three core track,other business proportion is not big,growth change irregular,in this paper,according to the history of different business development and competitiveness of each business sector separate growth rate evaluation analysis,in order to get more accurate future revenue,and then the parameters used in the EVA model is adjusted,to ensure the accuracy of the evaluation results and both cost impact.With EVA method to calculate the enterprise value,mindray medical value gap is too large and overvalued conclusion,to eliminate the market expectations of overvalued p/ e method revised EVA results,and revised the EVA value compared with the market value,combined with the realistic background,financial data and enterprise announcement analysis reason,finally put forward relevant Suggestions and summarize the shortcomings in this paper.